Whitaker has been writing about the treatment of the mentally ill for over 12 years. In Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs and the Astonishing Rise of Mental Illness in America, he examines what appears to be a trend toward poorer long-term outcomes for persons with major mental disorders, as compared to the era before modern psychopharmaceuticals. He posits that the timing is not coincidental, but that modern medications may be a contributing factor to these outcomes. Specifically, the medications are not very effective (i.e., that group outcomes for persons on modern psychotropic medications are minimally or not significantly better than placebo). More disturbingly, he reports that these medications are more than just ineffective, but may result in deleterious outcomes (i.e., that over time, many current pharmaceuticals may be altering the symptoms, course, and duration of several Axis I major mental illnesses). The author explicates the connections of medication to the changes in the prevalence and course of illness for persons with schizophrenia, unipolar and bipolar affective disorders, as well as anxiety disorders and disorders arising in childhood. He supports his propositions with references to research studies. Those cited include naturalistic studies as well as placebo-controlled medication trials of the present era. In this column I attempt to provide an informed analysis of several of the major research papers that underpin the theses, and some implications of the book and these studies for today’s psychiatric nurse professionals. This column is delimited to a review of cited research for only one diagnostic category: unipolar depression. In addition to the studies cited by Whitaker, I will report the findings on several newer studies in this same area. (Please see the book review